Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease

globenewswire

Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease – NEWSnet – News… as it used to be

More Press Releases

May 4, 2026

Propella Group and TISTR Sign MOU to Fast-Track Commercialization of Thailand’s Deep Tech IP

May 4, 2026

Panoro Announces Brokered LIFE Offering for Gross Proceeds of up to $20 Million

May 4, 2026

Athene Expands Registered Index-Linked Annuity (RILA) Lineup with Launch of Athene Amplify® 3.0

May 4, 2026

Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease

Propella Group and TISTR Sign MOU to Fast-Track Commercialization of Thailand’s Deep Tech IP

Panoro Announces Brokered LIFE Offering for Gross Proceeds of up to $20 Million

Athene Expands Registered Index-Linked Annuity (RILA) Lineup with Launch of Athene Amplify® 3.0

Bitget lists Billions Network (BILL) for Spot Trading